Acute nateglinide administration in subjects with type 2 diabetes: effects on postprandial metabolism, coagulation, and fibrinolysis.

Author: AnastasopoulouI, BoutatiE, KarafoullidouA, KarambakalisN, KatsilambrosN, KyriakiD, LouridaE, PereaD, PerreaD, RaptisS A, TentolourisN, TselepisA D, TsoukalaC

Paper Details 
Original Abstract of the Article :
Postprandial glycaemia and lipaemia are known risk factors for atherosclerosis in type 2 diabetes. Coagulation activation in the postprandial state also contributes to acceleration of atherosclerosis. Nateglinide is effective in reducing postprandial glycaemia. Its effect on glycaemia may also be be...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.numecd.2004.06.002

データ提供:米国国立医学図書館(NLM)

Nateglinide's Impact on Postprandial Metabolism in Type 2 Diabetes

This study investigates the effects of nateglinide, a medication used to manage type 2 diabetes, on postprandial metabolism, coagulation, and fibrinolysis. It’s like examining the intricate interactions of a desert ecosystem, where every element plays a role in maintaining balance. The study focuses on the impact of a single dose of nateglinide on postprandial glycemia, triglyceridemia, coagulation, and fibrinolysis, all key factors associated with the development of atherosclerosis in type 2 diabetes.

Nateglinide's Benefits in Postprandial Metabolism

The study found that a single dose of nateglinide effectively reduced postprandial glycemia, triglyceridemia, and coagulation. It’s like a calming oasis in the midst of a turbulent desert, offering a sense of relief and stability. These findings suggest that nateglinide may have a beneficial impact on cardiovascular health in type 2 diabetes patients by reducing the risk of atherosclerosis.

Implications for Type 2 Diabetes Management

This study provides valuable insights into the potential benefits of nateglinide in managing type 2 diabetes. It’s like discovering a hidden spring of water in the desert, providing a source of refreshment and nourishment. The study suggests that nateglinide could be a valuable tool for improving postprandial metabolic control and reducing the risk of cardiovascular complications in type 2 diabetes patients.

Dr.Camel's Conclusion

This study provides a deeper understanding of the effects of nateglinide on postprandial metabolism in type 2 diabetes. It’s like a careful exploration of a desert landscape, revealing the intricate connections between diet, medication, and health outcomes. The findings suggest that nateglinide may offer a promising approach to improving metabolic control and reducing the risk of cardiovascular complications in individuals with type 2 diabetes.

Date :
  1. Date Completed 2005-11-04
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

15871845

DOI: Digital Object Identifier

10.1016/j.numecd.2004.06.002

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.